| SCIENTURE HLDGS INC. O.N. |
| USA |
| Gesundheit |
| US80880X1046 / A40QA7 |
| 4E4 (Frankfurt) / SCNX (NASDAQ) |
| FRA:4E4, ETR:4E4, 4E4:GR, NASDAQ:SCNX |
| - |
| https://scienture.com/ |
|
Scienture Holdings operates as a specialty pharmaceutical company through its wholly owned subsidiary Scienture, LLC, focusing on developing and commercializing branded pharmaceutical products for central nervous system and cardiovascular diseases in..
>Volltext.. |
| 11.24 Mio. EUR |
| 5.55 Mio. EUR |
| 0.56 Mio. EUR |
| -14.78 Mio. EUR |
| -17.6 Mio. EUR |
| -1.55 EUR |
| 0.02 Mio. EUR |
| 5.71 Mio. EUR |
| -9.52 Mio. EUR |
| 2.44 |
| -73.18% |
| 18.35% |
| - |
| - |
| - |
| - |
| SCIENTURE |
| 08.04.26 |
|
||||
|
||||
|
||||
|
||||
|